• Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antibe Therapeutics Inc

+ Add to Watchlist

ATE:CN

0.4800 CAD 0.0200 4.00%

As of 13:51:51 ET on 11/26/2014.

Snapshot for Antibe Therapeutics Inc (ATE)

Open: 0.5000 Day's Range: 0.4800 - 0.5200 Volume: 47,900
Previous Close: 0.5000 52wk Range: 0.3900 - 0.8800 1-Yr Rtn: -26.15%

Stock Chart for ATE

No chart data available.
  • ATE:CN 0.4800
  • 1D
  • 1M
  • 1Y
0.5000
Interactive ATE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -0.1200
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 17.76
Shares Outstanding (M) 37.01
30 Day Average Volume 21,449
Price/Book (mrq) 6.0963
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATE

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ATE

Antibe Therapeutics Inc designs and develops new pharmaceuticals. The Company focuses on diseases characterized by inflammation, pain and/or vascular dysfunction.

Walter M Macnee "Walt"ChairmanDaniel Legault "Dan"Chief Executive Officer
Michael BumbyChief Financial OfficerJohn L WallaceChief Scientific Officer/Founder
More Company Profile & Key Executives for ATE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil